The FDA approved several spine-related devices last month.
Spinal Tech
From new board appointees to a neurostimulator snagging FDA approval, here are four key updates from spine and orthopedic device companies in the last week:
Medtronic, Stryker and Zimmer Biomet are all leaders in the medical device space for spine and orthopedics.
From increasing revenue growth to shifting spine strategy and FDA approvals, here are seven key Medtronic developments this year:
Aziyo Biologics, a regenerative medicine company, voluntarily recalled a lot of its FiberCel product after several patients who received it tested positive for tuberculosis, according to the FDA.
DiFusion Technologies added Todd Potokar to its board of directors and named Rich Grant as chair of the board.
The FDA granted several knee, hip, shoulder and spine devices 510(k) clearance in May.
The FDA has provided clearance for Medtronic's Vanta, a recharge free implantable neurostimulator.
Zimmer Biomet approved cash dividends for the second quarter of the 2021 fiscal year, the company announced June 10.
The Machine-vision Image Guided Surgery System is one of the many technologies spine surgeons have at their disposal at the Connecticut Orthopaedic Institute in Bridgeport, News12 Westchester reports.
